<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644607/" ref="ordinalpos=3311&amp;ncbi_uid=6075883&amp;link_uid=PMC3644607" image-link="/pmc/articles/PMC3644607/figure/F2/" class="imagepopup">Figure 2. From: Prioritizing Genetic Testing in Patients With Kallmann Syndrome Using Clinical Phenotypes. </a></div><br /><div class="p4l_captionBody">Pubertal severity at presentation in male KS probands. A, Individual values of TV at presentation in male probands within each gene/signaling group. Prepubertal TV less than 4 mL and pubertal TV of 4 mL or greater. KAL1, KAL1; FGF, FGF8/FGFR1 signaling pathway; PROK, PROK2/PROKR2 signaling pathway; CHD7, CHD7; Neg, geneâ€“negative group; HS, HS6ST1. B, Comparison of individual TV at presentation between probands harboring KAL1 mutations (KAL1 group) vs probands who were negative for KAL1 mutations (non-KAL1 group). *P &lt; .05</div></div>